世界の静脈内（IV）鉄投与療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Intravenous (IV) Iron Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4394
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、静脈内（IV）鉄投与療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カルボキシマルトース鉄、鉄スクロース、鉄デキストラン、その他）、用途別市場規模（腎臓内科、婦人科・産科、消化器内科、腫瘍内科、循環器内科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・静脈内（IV）鉄投与療法の市場動向
・企業の競争状況、市場シェア
・静脈内（IV）鉄投与療法の種類別市場規模と予測2016-2027（カルボキシマルトース鉄、鉄スクロース、鉄デキストラン、その他）
・静脈内（IV）鉄投与療法の用途別市場規模と予測2016-2027（腎臓内科、婦人科・産科、消化器内科、腫瘍内科、循環器内科、その他）
・静脈内（IV）鉄投与療法の北米市場規模2016-2027（アメリカ、カナダ）
・静脈内（IV）鉄投与療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・静脈内（IV）鉄投与療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・静脈内（IV）鉄投与療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・静脈内（IV）鉄投与療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sanofi、Allergan、AMAG Pharmaceuticals、Dalichi Sankyo、Luitpold Pharmaceuticals、Pharmacosmos、Takeda Pharmaceutical）
・結論

Market Analysis and Insights: Global Intravenous (IV) Iron Therapy Market
The global Intravenous (IV) Iron Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intravenous (IV) Iron Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intravenous (IV) Iron Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intravenous (IV) Iron Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intravenous (IV) Iron Therapy market.

Global Intravenous (IV) Iron Therapy Scope and Market Size
Intravenous (IV) Iron Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Iron Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others

Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Others
1.3 Market by Application
1.3.1 Global Intravenous (IV) Iron Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Intravenous (IV) Iron Therapy Market Perspective (2016-2027)
2.2 Intravenous (IV) Iron Therapy Growth Trends by Regions
2.2.1 Intravenous (IV) Iron Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Intravenous (IV) Iron Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Intravenous (IV) Iron Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Intravenous (IV) Iron Therapy Industry Dynamic
2.3.1 Intravenous (IV) Iron Therapy Market Trends
2.3.2 Intravenous (IV) Iron Therapy Market Drivers
2.3.3 Intravenous (IV) Iron Therapy Market Challenges
2.3.4 Intravenous (IV) Iron Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Intravenous (IV) Iron Therapy Players by Revenue
3.1.1 Global Top Intravenous (IV) Iron Therapy Players by Revenue (2016-2021)
3.1.2 Global Intravenous (IV) Iron Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Intravenous (IV) Iron Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Intravenous (IV) Iron Therapy Revenue
3.4 Global Intravenous (IV) Iron Therapy Market Concentration Ratio
3.4.1 Global Intravenous (IV) Iron Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Iron Therapy Revenue in 2020
3.5 Intravenous (IV) Iron Therapy Key Players Head office and Area Served
3.6 Key Players Intravenous (IV) Iron Therapy Product Solution and Service
3.7 Date of Enter into Intravenous (IV) Iron Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Intravenous (IV) Iron Therapy Breakdown Data by Type
4.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Type (2016-2021)
4.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2022-2027)

5 Intravenous (IV) Iron Therapy Breakdown Data by Application
5.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Application (2016-2021)
5.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Intravenous (IV) Iron Therapy Market Size (2016-2027)
6.2 North America Intravenous (IV) Iron Therapy Market Size by Type
6.2.1 North America Intravenous (IV) Iron Therapy Market Size by Type (2016-2021)
6.2.2 North America Intravenous (IV) Iron Therapy Market Size by Type (2022-2027)
6.2.3 North America Intravenous (IV) Iron Therapy Market Size by Type (2016-2027)
6.3 North America Intravenous (IV) Iron Therapy Market Size by Application
6.3.1 North America Intravenous (IV) Iron Therapy Market Size by Application (2016-2021)
6.3.2 North America Intravenous (IV) Iron Therapy Market Size by Application (2022-2027)
6.3.3 North America Intravenous (IV) Iron Therapy Market Size by Application (2016-2027)
6.4 North America Intravenous (IV) Iron Therapy Market Size by Country
6.4.1 North America Intravenous (IV) Iron Therapy Market Size by Country (2016-2021)
6.4.2 North America Intravenous (IV) Iron Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Intravenous (IV) Iron Therapy Market Size (2016-2027)
7.2 Europe Intravenous (IV) Iron Therapy Market Size by Type
7.2.1 Europe Intravenous (IV) Iron Therapy Market Size by Type (2016-2021)
7.2.2 Europe Intravenous (IV) Iron Therapy Market Size by Type (2022-2027)
7.2.3 Europe Intravenous (IV) Iron Therapy Market Size by Type (2016-2027)
7.3 Europe Intravenous (IV) Iron Therapy Market Size by Application
7.3.1 Europe Intravenous (IV) Iron Therapy Market Size by Application (2016-2021)
7.3.2 Europe Intravenous (IV) Iron Therapy Market Size by Application (2022-2027)
7.3.3 Europe Intravenous (IV) Iron Therapy Market Size by Application (2016-2027)
7.4 Europe Intravenous (IV) Iron Therapy Market Size by Country
7.4.1 Europe Intravenous (IV) Iron Therapy Market Size by Country (2016-2021)
7.4.2 Europe Intravenous (IV) Iron Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Intravenous (IV) Iron Therapy Market Size (2016-2027)
8.2 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Type
8.2.1 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Application
8.3.1 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region
8.4.1 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Intravenous (IV) Iron Therapy Market Size (2016-2027)
9.2 Latin America Intravenous (IV) Iron Therapy Market Size by Type
9.2.1 Latin America Intravenous (IV) Iron Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Intravenous (IV) Iron Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Intravenous (IV) Iron Therapy Market Size by Type (2016-2027)
9.3 Latin America Intravenous (IV) Iron Therapy Market Size by Application
9.3.1 Latin America Intravenous (IV) Iron Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Intravenous (IV) Iron Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Intravenous (IV) Iron Therapy Market Size by Application (2016-2027)
9.4 Latin America Intravenous (IV) Iron Therapy Market Size by Country
9.4.1 Latin America Intravenous (IV) Iron Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Intravenous (IV) Iron Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Intravenous (IV) Iron Therapy Market Size (2016-2027)
10.2 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Type
10.2.1 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Application
10.3.1 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country
10.4.1 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Intravenous (IV) Iron Therapy Introduction
11.1.4 Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Intravenous (IV) Iron Therapy Introduction
11.2.4 Allergan Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 AMAG Pharmaceuticals
11.3.1 AMAG Pharmaceuticals Company Details
11.3.2 AMAG Pharmaceuticals Business Overview
11.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
11.3.4 AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.3.5 AMAG Pharmaceuticals Recent Development
11.4 Dalichi Sankyo
11.4.1 Dalichi Sankyo Company Details
11.4.2 Dalichi Sankyo Business Overview
11.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Introduction
11.4.4 Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.4.5 Dalichi Sankyo Recent Development
11.5 Luitpold Pharmaceuticals
11.5.1 Luitpold Pharmaceuticals Company Details
11.5.2 Luitpold Pharmaceuticals Business Overview
11.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
11.5.4 Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.5.5 Luitpold Pharmaceuticals Recent Development
11.6 Pharmacosmos
11.6.1 Pharmacosmos Company Details
11.6.2 Pharmacosmos Business Overview
11.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Introduction
11.6.4 Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.6.5 Pharmacosmos Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Introduction
11.7.4 Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ferric Carboxymaltose
Table 3. Key Players of Iron Sucrose
Table 4. Key Players of Iron Dextran
Table 5. Key Players of Others
Table 6. Global Intravenous (IV) Iron Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Intravenous (IV) Iron Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Intravenous (IV) Iron Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Intravenous (IV) Iron Therapy Market Share by Regions (2016-2021)
Table 10. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Intravenous (IV) Iron Therapy Market Share by Regions (2022-2027)
Table 12. Intravenous (IV) Iron Therapy Market Trends
Table 13. Intravenous (IV) Iron Therapy Market Drivers
Table 14. Intravenous (IV) Iron Therapy Market Challenges
Table 15. Intravenous (IV) Iron Therapy Market Restraints
Table 16. Global Intravenous (IV) Iron Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Intravenous (IV) Iron Therapy Market Share by Players (2016-2021)
Table 18. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Iron Therapy as of 2020)
Table 19. Ranking of Global Top Intravenous (IV) Iron Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Intravenous (IV) Iron Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Intravenous (IV) Iron Therapy Product Solution and Service
Table 23. Date of Enter into Intravenous (IV) Iron Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Intravenous (IV) Iron Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Intravenous (IV) Iron Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Intravenous (IV) Iron Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Intravenous (IV) Iron Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Intravenous (IV) Iron Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Intravenous (IV) Iron Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Intravenous (IV) Iron Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Intravenous (IV) Iron Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Intravenous (IV) Iron Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Intravenous (IV) Iron Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Intravenous (IV) Iron Therapy Product
Table 66. Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Allergan Company Details
Table 69. Allergan Business Overview
Table 70. Allergan Intravenous (IV) Iron Therapy Product
Table 71. Allergan Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 72. Allergan Recent Development
Table 73. AMAG Pharmaceuticals Company Details
Table 74. AMAG Pharmaceuticals Business Overview
Table 75. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Product
Table 76. AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 77. AMAG Pharmaceuticals Recent Development
Table 78. Dalichi Sankyo Company Details
Table 79. Dalichi Sankyo Business Overview
Table 80. Dalichi Sankyo Intravenous (IV) Iron Therapy Product
Table 81. Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 82. Dalichi Sankyo Recent Development
Table 83. Luitpold Pharmaceuticals Company Details
Table 84. Luitpold Pharmaceuticals Business Overview
Table 85. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Product
Table 86. Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 87. Luitpold Pharmaceuticals Recent Development
Table 88. Pharmacosmos Company Details
Table 89. Pharmacosmos Business Overview
Table 90. Pharmacosmos Intravenous (IV) Iron Therapy Product
Table 91. Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 92. Pharmacosmos Recent Development
Table 93. Takeda Pharmaceutical Company Details
Table 94. Takeda Pharmaceutical Business Overview
Table 95. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Product
Table 96. Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2016-2021) & (US$ Million)
Table 97. Takeda Pharmaceutical Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous (IV) Iron Therapy Market Share by Type: 2020 VS 2027
Figure 2. Ferric Carboxymaltose Features
Figure 3. Iron Sucrose Features
Figure 4. Iron Dextran Features
Figure 5. Others Features
Figure 6. Global Intravenous (IV) Iron Therapy Market Share by Application: 2020 VS 2027
Figure 7. Nephrology Case Studies
Figure 8. Gynecology & Obstetrics Case Studies
Figure 9. Gastroenterology Case Studies
Figure 10. Oncology Case Studies
Figure 11. Cardiology Case Studies
Figure 12. Others Case Studies
Figure 13. Intravenous (IV) Iron Therapy Report Years Considered
Figure 14. Global Intravenous (IV) Iron Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Intravenous (IV) Iron Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Intravenous (IV) Iron Therapy Market Share by Regions: 2020 VS 2027
Figure 17. Global Intravenous (IV) Iron Therapy Market Share by Regions (2022-2027)
Figure 18. Global Intravenous (IV) Iron Therapy Market Share by Players in 2020
Figure 19. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Iron Therapy as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2020
Figure 21. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2016-2021)
Figure 22. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2022-2027)
Figure 23. North America Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Intravenous (IV) Iron Therapy Market Share by Type (2016-2027)
Figure 25. North America Intravenous (IV) Iron Therapy Market Share by Application (2016-2027)
Figure 26. North America Intravenous (IV) Iron Therapy Market Share by Country (2016-2027)
Figure 27. United States Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Intravenous (IV) Iron Therapy Market Share by Type (2016-2027)
Figure 31. Europe Intravenous (IV) Iron Therapy Market Share by Application (2016-2027)
Figure 32. Europe Intravenous (IV) Iron Therapy Market Share by Country (2016-2027)
Figure 33. Germany Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Region (2016-2027)
Figure 43. China Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Intravenous (IV) Iron Therapy Market Share by Type (2016-2027)
Figure 51. Latin America Intravenous (IV) Iron Therapy Market Share by Application (2016-2027)
Figure 52. Latin America Intravenous (IV) Iron Therapy Market Share by Country (2016-2027)
Figure 53. Mexico Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Intravenous (IV) Iron Therapy Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Intravenous (IV) Iron Therapy Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Intravenous (IV) Iron Therapy Market Share by Country (2016-2027)
Figure 59. Turkey Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Intravenous (IV) Iron Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Sanofi Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 64. AMAG Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 65. Dalichi Sankyo Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 66. Luitpold Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 67. Pharmacosmos Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 68. Takeda Pharmaceutical Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Global Intravenous(IV) Therapy and Vein Access Market Size, Status and Forecast 2021-2027
QFJ1-4395 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、静脈内（IV）療法＆静脈アクセスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（輸液ポンプ、植込み型ポート、静脈注射カテーテル、皮下注射針、その他）、用途別市場規模（病院、クリニック、その他）、主要地...

世界の滅菌静脈注射（IV）溶液市場規模・現状・予測（2021年-2027年）

Global Sterile Intravenous (IV) Solution Market Size, Status and Forecast 2021-2027
QFJ1-4904 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、滅菌静脈注射（IV）溶液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリスタロイド、コロイド、その他）、用途別市場規模（医薬品、栄養、血液系製品、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の重粒子線治療市場規模・現状・予測（2021年-2027年）

Global Heavy Ion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5188 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、重粒子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、サービス）、用途別市場規模（科学研究所、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の静脈内チューブセット＆付属品市場規模・現状・予測（2021年-2027年）

Global Intravenous Tubing Sets and Accessories Market Size, Status and Forecast 2021-2027
QFJ1-5217 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、静脈内チューブセット＆付属品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IVセット、カニューレ、チューブ、針、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場...

世界の外来点滴療法市場規模・現状・予測（2021年-2027年）

Global Ambulatory Infusion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3788 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、外来点滴療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（輸液ポンプ、点滴セット、その他機器、輸液療法サービス）、用途別市場規模（病院、診療所、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のCD抗原がん治療市場規模・現状・予測（2021年-2027年）

Global CD Antigen Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3982 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、CD抗原がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、皮下、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の補助療法市場規模・現状・予測（2021年-2027年）

Global Adjuvant Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3765 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、補助療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のTCR-T療法試薬市場規模・現状・予測（2021年-2027年）

Global TCR-T Therapy Reagent Market Size, Status and Forecast 2021-2027
QFJ1-4940 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、TCR-T療法試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血清試薬、抗体試薬、タンパク質試薬、その他）、用途別市場規模（病院、バイオラボ、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のパラフィン理学療法市場規模・現状・予測（2021年-2027年）

Global Paraffin Physical Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4653 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、パラフィン理学療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（即時使用可能パラフィン理学療法、即時加熱可能パラフィン理学療法）、用途別市場規模（病院、クリニック、若返りセンター）、主要地域別市場規...

世界の時差ボケ治療薬市場規模・現状・予測（2021年-2027年）

Global Jet Lag Therapy Pharmaceuticals Market Size, Status and Forecast 2021-2027
QFJ1-5816 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、時差ボケ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の静脈内（IV）療法＆静脈アクセス市場規模・現状・予測（2021年-2027年） IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products. Market Analysis and Insights: Global Intravenous(IV) Therapy and Vein Access Market The global Intravenous(IV) Therapy and Vein Access marke…
世界のIV＆経口鉄剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global IV and Oral Iron Drugs Market The global IV and Oral Iron Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の海綿鉄粉（SIP）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sponge Iron Powder (SIP) Market The global Sponge Iron Powder (SIP) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の鉄欠乏性貧血治療薬市場規模・現状・予測（2021年-2027年） Iron deficiency anemia is a decrease in the red cells of the blood caused by too little iron.The most economical and effective medical treatment for iron deficiency anemia is the oral administration of ferrous iron salts. Market Analysis and Insights: Global Iron Deficiency Anemia Drug Market The gl…
鉄キレート化剤のグローバル市場2021 This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely t…